-
1.发明申请USE OF SPHINGOMYELIN AND NON-DIGESTIBLE CARBOHYDRATES FOR IMPROVING INTESTINAL MICROBIOTA 审中-公开用于改善肠溶微生物的丝氨酸蛋白酶和非可饮用碳水化合物的使用公开(公告)号：US20110034407A1
公开(公告)日：2011-02-10
申请号：US12809519
申请日：2008-12-19
申请人： Willem Ferdinand Nieuwenhuizen , Kaouther Ben Amor , Jan Knol , Eline Marleen Van Der Beek , Christopher Beermann , Guenther Boehm
发明人： Willem Ferdinand Nieuwenhuizen , Kaouther Ben Amor , Jan Knol , Eline Marleen Van Der Beek , Christopher Beermann , Guenther Boehm
IPC分类号： A61K31/715 , A61K31/733 , A61P29/00 , A61P11/06 , A61P17/00 , A61P1/00 , A61P3/00
CPC分类号： A61K31/733 , A23L33/21 , A23L33/40 , A23V2002/00 , A61K31/133 , A61K31/688 , A61K31/702 , A23V2200/3202
摘要： A composition comprising sphingophospholipid or its degradation product and at least one non-digestible carbohydrate for providing and/or maintaining an optimal intestinal microbiota is provided. The composition is especially suitable for infant nutrition.
摘要翻译： 提供了包含鞘磷脂或其降解产物和用于提供和/或维持最佳肠微生物群的至少一种不可消化的碳水化合物的组合物。 该组合物特别适用于婴幼儿营养。
-
2.发明授权Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids 有权具有含核心的脂质球的营养组合物包含植物脂质和包含磷脂或极性脂质的包衣公开(公告)号：US09320294B2
公开(公告)日：2016-04-26
申请号：US13061643
申请日：2009-09-02
IPC分类号： A23L1/30 , A23L1/29 , A61K31/201 , A61K35/60 , A61K36/02
CPC分类号： A61K31/575 , A23L33/115 , A23L33/21 , A23L33/30 , A23L33/40 , A23V2002/00 , A61K31/201 , A61K31/683 , A61K31/7028 , A61K35/60 , A61K36/02 , A61K2300/00
摘要： The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a large lipid globule size. The composition can be used to prevent obesity and/or improve body composition later in life. Said lipid component comprises 10-50 wt % vegetable lipids, and the lipid globules have a volume-weighted diameter above 1.0 m and/or a diameter of 2-12 m in an amount of at least 45 vol %.
摘要翻译： 本发明涉及包含脂质组分的婴儿和/或幼儿的营养组合物，所述脂质组分具有大的脂质球尺寸。 该组合物可用于预防肥胖和/或改善身体后期的身体组成。 所述脂质组分包含10-50重量％的植物脂质，并且所述脂质球体具有至少45体积％的量的体积加权直径大于1.0微米和/或2-12微米的直径。
-
3.发明授权Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution 有权具有高蛋白质和长链多不饱和脂肪酸的人乳强化剂，用于改善身体脂肪组织分布公开(公告)号：US09089533B2
公开(公告)日：2015-07-28
申请号：US13321499
申请日：2010-05-19
申请人： Eline Marleen van der Beek , Günther Boehm , Christopher Beermann , Neena Modi , Jimmy David Bell
发明人： Eline Marleen van der Beek , Günther Boehm , Christopher Beermann , Neena Modi , Jimmy David Bell
CPC分类号： A61K35/20 , A23L33/12 , A23L33/40 , A23V2002/00 , A23V2200/332 , A23V2250/1868 , A23V2250/1882 , A61K38/12
摘要： The present invention relates to human milk fortifiers comprising high protein content and long chain poly-unsaturated fatty acids. Use of such human milk fortifier improves the body adipose tissue distribution by increasing the subcutaneous adipose tissue mass, while at the same time not increasing visceral adipose tissue.
摘要翻译： 本发明涉及包含高蛋白质含量和长链多不饱和脂肪酸的人乳强化剂。 使用这种人乳强化剂通过增加皮下脂肪组织质量来改善身体脂肪组织分布，同时不增加内脏脂肪组织。
-
4.发明申请HUMAN MILK FORTIFIER WITH HIGH PROTEIN AND LONG CHAIN POLY UNSATURATED FATTY ACIDS FOR IMPROVING BODY ADIPOSE TISSUE DISTRIBUTION 有权具有高蛋白质和长链多重不饱和脂肪酸的人乳制品改善身体组织组织分布公开(公告)号：US20120121756A1
公开(公告)日：2012-05-17
申请号：US13321499
申请日：2010-05-19
申请人： Eline Marleen van der Beek , Günther Boehm , Christopher Beermann , Neena Modi , Jimmy David Bell
发明人： Eline Marleen van der Beek , Günther Boehm , Christopher Beermann , Neena Modi , Jimmy David Bell
CPC分类号： A61K35/20 , A23L33/12 , A23L33/40 , A23V2002/00 , A23V2200/332 , A23V2250/1868 , A23V2250/1882 , A61K38/12
摘要： The present invention relates to human milk fortifiers comprising high protein content and long chain poly-unsaturated fatty acids. Use of such human milk fortifier improves the body adipose tissue distribution by increasing the subcutaneous adipose tissue mass, while at the same time not increasing visceral adipose tissue.
摘要翻译： 本发明涉及包含高蛋白质含量和长链多不饱和脂肪酸的人乳强化剂。 使用这种人乳强化剂通过增加皮下脂肪组织质量来改善身体脂肪组织分布，同时不增加内脏脂肪组织。
-
5.发明申请USE OF NON-DIGESTABLE SACHARIDES FOR GIVING AN INFANT THE BEST START AFTER BIRTH 审中-公开使用不可食用的沙发提供婴儿是出生后最好的开始公开(公告)号：US20090305996A1
公开(公告)日：2009-12-10
申请号：US12282302
申请日：2007-03-09
IPC分类号： A61K31/70 , A61K31/702 , A61P37/00
CPC分类号： A61K31/702 , A23L33/115 , A23L33/21 , A23L33/30 , A23V2002/00 , A23V2200/324 , A23V2250/28 , A23V2250/1882 , A61K2300/00
摘要： A food or supplement for pregnant women comprising water soluble, non-digestible saccharides is described. The composition is used to improve the flora and/or immune system of the pregnant women, to improve the immune system of the infant and to improve the intestinal flora of the infant after birth.
摘要翻译： 描述了包含水溶性，不可消化的糖的孕妇的食物或补充剂。 该组合物用于改善孕妇的植物和/或免疫系统，改善婴儿的免疫系统并改善出生后的婴儿肠道菌群。
-
公开(公告)号：US20120195975A1
公开(公告)日：2012-08-02
申请号：US13360508
申请日：2012-01-27
CPC分类号： A61K31/201 , A23L33/12 , A23L33/19 , A23L33/22 , A23L33/40 , A23V2002/00 , A61K31/702 , A61K31/7052 , A61K31/715 , A23V2250/28 , A23V2250/5046 , A23V2250/1872 , A23V2250/1874 , A23V2250/187 , A23V2250/1868 , A23V2250/1862 , A23V2250/5072
摘要： A nutritional or pharmaceutical composition comprising fat, protein, carbohydrate, whey and casein is provided. The composition has a weight ratio of casein to whey between 1:1 to 1:2.4 and comprises: a) at least 3 grams arginine per 100 grams protein; b) at least 10 wt. % linoleic acid based on total fatty acids; c) at least 1 wt. % alpha linolenic acid based on total fatty acids; d) at least one long chain-polyunsaturated fatty acid in an amount exceeding 0.1 wt. % based on total fatty acids selected from docosahexaenoic acid, arachidonic acid and eicosapentaenoic acid; e) 5 to 25 wt. % of at least one polyunsaturated fatty acid based on total fatty acids; and f) 2 to 12 grams indigestible oligosaccharides having a degree of polymerisation of 2 to 100 per 100 gram dry weight of the composition. Methods of treatment by administering the composition are also provided.
摘要翻译： 提供了包含脂肪，蛋白质，碳水化合物，乳清和酪蛋白的营养或药物组合物。 该组合物的酪蛋白与乳清的重量比在1:1至1:2.4之间，包括：a）每100克蛋白质至少3克精氨酸; b）至少10wt。 ％亚油酸基于总脂肪酸; c）至少1wt。 基于总脂肪酸的％α亚麻酸; d）至少一种超过0.1重量％的长链多不饱和脂肪酸。 基于选自二十二碳六烯酸，花生四烯酸和二十碳五烯酸的总脂肪酸的％; e）5至25wt。 至少一种基于总脂肪酸的多不饱和脂肪酸的％; 和f）2至12克不可消化的低聚糖，其聚合度为每100克组合物干重2至100。 还提供了施用该组合物的治疗方法。
-
公开(公告)号：US20090054329A1
公开(公告)日：2009-02-26
申请号：US12094130
申请日：2006-11-16
IPC分类号： A61K38/16 , A61K31/202 , A61K31/715 , A61P1/14
CPC分类号： A61K31/202
摘要： This invention concerns a method for stimulating barrier integrity in a subject by administering to a subject a composition comprising docosapentaenoic acid (22:5 n3; DPA). Also the invention concerns a composition comprising DPA and eicosapentaenoic acid (EPA).
摘要翻译： 本发明涉及一种通过向受试者施用包含二十二碳五烯酸（22:5n3; DPA）的组合物来刺激受试者的屏障完整性的方法。 本发明还涉及包含DPA和二十碳五烯酸（EPA）的组合物。
-
公开(公告)号：US20050075310A1
公开(公告)日：2005-04-07
申请号：US10497173
申请日：2003-05-27
申请人： Christopher Beermann , Lars Bode , Gunther Boehm
发明人： Christopher Beermann , Lars Bode , Gunther Boehm
IPC分类号： A23L1/29 , A23L1/30 , A61K31/7004 , A61K31/7028 , A61P3/02 , C07H15/10 , A61K31/739 , C08B37/00
CPC分类号： C07H15/10 , A23L33/105 , A23L33/40 , A61K31/7028 , A61K2300/00
摘要： The invention relates to a ganglioside mixture, consisting of gangliosides, of the following general formula: (sugar)-OCH2—CH(—NH—CO—R1)—CH(OH)—CH=CH-R2, wherein (sugar) represents a sugar radical, the group —CO—R1 represents an acyl-fatty acid which is bonded to the radical of the molecule in the form of an amide, R1 represents a straight saturated alkyl radical having at least 10 C-atoms and R2 represents a straight, saturated alkyl radical having at least 10 C-atoms or a straight alkenyl radical having at least 10 C-atoms and one, two or three double bond(s). Said mixture is characterised in that at least 10 wt. % of the gangliosides of the general formula I are of the group —CO—R1 and the acyl-fatty acids are a C20:0 fatty acid. Said mixtures exhibit an improved biological activity.
摘要翻译： 本发明涉及神经节苷脂混合物，由神经节苷脂组成，具有以下通式：（糖）-OCH 2 -CH（-NH-CO-R 1）-CH（OH）-CH = CH-R 2 ，其中（糖）表示糖基，基团-CO-R 1表示与酰基形式的分子基团结合的酰基脂肪酸，R 1表示直链饱和烷基 具有至少10个C原子的基团和R 2表示具有至少10个C原子的直链饱和烷基或具有至少10个C原子和一个，两个或三个双键的直链烯基， 。 所述混合物的特征在于，至少10wt。 通式I的神经节苷脂的％为-CO-R 1基团，酰基脂肪酸为C20：0脂肪酸。 所述混合物表现出改善的生物活性。
-
公开(公告)号：US09084433B2
公开(公告)日：2015-07-21
申请号：US13594147
申请日：2012-08-24
申请人： Eric Alexander Franciscus Van Tol , Linette Eustachia Maria Willemsen , Marleen Antoinette Koetsier , Christopher Beermann , Bernd Stahl
发明人： Eric Alexander Franciscus Van Tol , Linette Eustachia Maria Willemsen , Marleen Antoinette Koetsier , Christopher Beermann , Bernd Stahl
CPC分类号： A23L29/04 , A23L29/30 , A23L33/12 , A23L33/40 , A23V2002/00 , A61K31/202 , A61K31/702 , A23V2200/32 , A23V2200/304 , A23V2250/187 , A23V2250/1868 , A23V2250/1862 , A23V2250/28 , A23V2250/5062
摘要： The invention concerns a method for stimulating barrier integrity in a mammal by administering to a mammal a composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides.
摘要翻译： 本发明涉及通过向哺乳动物施用包含二十碳五烯酸（EPA），二十二碳六烯酸（DHA）和花生四烯酸（ARA）以及至少两种不同的低聚糖的组合物来刺激哺乳动物的屏障完整性的方法。
-
公开(公告)号：US08580316B2
公开(公告)日：2013-11-12
申请号：US13360508
申请日：2012-01-27
CPC分类号： A61K31/201 , A23L33/12 , A23L33/19 , A23L33/22 , A23L33/40 , A23V2002/00 , A61K31/702 , A61K31/7052 , A61K31/715 , A23V2250/28 , A23V2250/5046 , A23V2250/1872 , A23V2250/1874 , A23V2250/187 , A23V2250/1868 , A23V2250/1862 , A23V2250/5072
摘要： A nutritional or pharmaceutical composition comprising fat, protein, carbohydrate, whey and casein is provided. The composition has a weight ratio of casein to whey between 1:1 to 1:2.4 and comprises: a) at least 3 grams arginine per 100 grams protein; b) at least 10 wt. % linoleic acid based on total fatty acids; c) at least 1 wt. % alpha linolenic acid based on total fatty acids; d) at least one long chain-polyunsaturated fatty acid in an amount exceeding 0.1 wt. % based on total fatty acids selected from docosahexaenoic acid, arachidonic acid and eicosapentaenoic acid; e) 5 to 25 wt. % of at least one polyunsaturated fatty acid based on total fatty acids; and 2 to 12 grams indigestible oligosaccharides having a degree of polymerisation of 2 to 100 per 100 gram dry weight of the composition. Methods of treatment by administering the composition are also provided.
摘要翻译： 提供了包含脂肪，蛋白质，碳水化合物，乳清和酪蛋白的营养或药物组合物。 该组合物的酪蛋白与乳清的重量比在1:1至1:2.4之间，包括：a）每100克蛋白质至少3克精氨酸; b）至少10wt。 ％亚油酸基于总脂肪酸; c）至少1wt。 基于总脂肪酸的％α亚麻酸; d）至少一种超过0.1重量％的长链多不饱和脂肪酸。 基于选自二十二碳六烯酸，花生四烯酸和二十碳五烯酸的总脂肪酸的％; e）5至25wt。 至少一种基于总脂肪酸的多不饱和脂肪酸的％; 和2至12克不可消化的寡糖，其组合物的每100克干重具有聚合度为2至100。 还提供了施用组合物的治疗方法。
-
-
-
-
-
-
-
-
-
搜索结果
23 条记录 (耗时 0.031 秒)
